Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Oct 2026 for Disc Medicine, Inc., €812k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Atlas Venture Opportunity Fund II, L.P.: trading record in brief
Filings by Atlas Venture Opportunity Fund II, L.P. span 3 companies, the busiest being Korro Bio, Inc., Dyne Therapeutics, Inc. and Disc Medicine, Inc. We count 24 filings; the first trade dates from 22 June 2026 and the latest from 21 October 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 21 October 2026: a transaction of €812k, in Disc Medicine, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Atlas Venture Opportunity Fund II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
11,470 shares@ US$79.48Common StockSEC144:0001628280-26-066749
2,388 shares@ US$78.930.0063% mcap26.6% of flowCommon StockSEC144:0001628280-26-066537
4,942 shares@ US$56.840.0093% mcap54.0% of flowCommon StockSEC144:0001628280-26-066327
6,602 shares@ US$13.810.067% mcap4.6% of flowCommon StockSEC144:0001628280-26-061897
1,750 shares@ US$13.060.017% mcap1.1% of flowCommon StockSEC144:0001628280-26-061592
759 shares@ US$79.370.0023% mcap24.3% of flowCommon StockSEC144:0001628280-26-060747
2,339 shares@ US$80.050.0072% mcap75.7% of flowCommon StockSEC144:0001628280-26-060505
51 shares@ US$13.730.0005% mcap0.0% of flowCommon StockSEC144:0001628280-26-059121
4,884 shares@ US$13.220.045% mcap3.2% of flowCommon StockSEC144:0001628280-26-058029
478,377 shares@ US$25.960.40% mcap51.9% of flowCommonSEC144:0001628280-26-057188
94,415 shares@ US$26.170.079% mcap10.3% of flowCommonSEC144:0001628280-26-056844
368 shares@ US$13.490.0035% mcap0.3% of flowCommon StockSEC144:0001628280-26-055859
77,387 shares@ US$22.840.057% mcap7.4% of flowCommonSEC144:0001628280-26-047532
8,506 shares@ US$14.000.084% mcap6.1% of flowCommon StockSEC144:0001628280-26-047351
127,182 shares@ US$23.070.095% mcap12.4% of flowCommonSEC144:0001628280-26-047355
14,745 shares@ US$13.650.14% mcap10.3% of flowCommon StockSEC144:0001628280-26-046980
51,756 shares@ US$20.940.035% mcap4.6% of flowCommonSEC144:0001628280-26-046096
81,903 shares@ US$20.610.035% mcap7.2% of flowCommonSEC144:0001628280-26-045820
6,382 shares@ US$20.330.0027% mcap0.6% of flowCommonSEC144:0001628280-26-045613
7,093 shares@ US$13.710.048% mcap5.0% of flowCommon StockSEC144:0001628280-26-045301
25,397 shares@ US$20.260.011% mcap2.2% of flowCommonSEC144:0001628280-26-045297
39,131 shares@ US$20.870.017% mcap3.5% of flowCommonSEC144:0001628280-26-044987
17,426 shares@ US$13.900.12% mcap12.4% of flowCommon StockSEC144:0001628280-26-044983
3,661 shares@ US$12.990.023% mcap2.4% of flowCommon StockSEC144:0001628280-26-044737
24 of 24 declarations
